The African Meningitis Trials Network (AMNET) was established in October 2017. The network brings together African and European Clinical Researchers whose main aim is to reduce the large number of deaths caused by meningitis in Africa through collaborative clinical rials. It is currently supported by the AMBITION Study (high dose Ambisome on a fluconazole backbone for cryptococcal meningitis induction therapy in Sub-Saharan Africa : a randomized controlled non-inferiority trial).

We believe collaborative activities are part of research excellence and we are seeking new collaborators doing Meningitis Research across the African continent. Fill in the contact form here and join an outstanding team of excellent researchers.

The objective of the Network is to build on existing experience, resources and infrastructure in order to enable other institutions and researchers to build on the AMBITION experience. The hope is that this will streamline the development of large, international randomized controlled trials in the future.

The Network includes the following partner institutions:

Botswana – Harvard Partnership  University of Cape Town University of Zimbabwe
 Infectious Diseases Institute UNC Project Malawi  Malawi – Liverpool Wellcome Trust Clinical Research Program


The 2nd African Meningitis Trials Network Face-to-Face Meeting was held on the 09th of July in Cape Town, South Africa at the University of Cape Town (UCT). Read all about the meeting here.

The 3rd face-to-face meeting will be in June 2020 in Uganda! Look out for the dates!


The programme will respond to the critical gaps that were identified in building the continent’s research and development ecosystems which support a vibrant research culture and leadership. The overall goal of ReMPro Africa is to address systemic level challenges in African institutions to create and sustain an enabling research environment that can enhance research.

Professor Tom Kariuki, the AAS Programmes Director, said majority of African researchers often spend more than 80% of their time on routine administration and dedicate little time for research. Read more on ReMPro here.


The Clinical Research and Development Fellowship (CRDF) scheme is jointly implemented by EDCTP (European-Developing Countries Clinical Trial Partnership) and TDR.

The purpose of the TDR CRDF is to provide funding support to researchers and clinical trial staff from LMICs to acquire essential skills in clinical research and development through placements in host training organizations. The scheme targets early to mid-career researchers or clinical trial staff who are employed by a legal entity in LMICs where they are currently conducting clinical research activities in the scope of TDR. Deadline for submissions is 28 February 2020. More information on the joint call available here.

SAVE THE DATE : AMNET/ International Conference on Cryptococcus & Cryptococcosis (ICCC 2020)

The 3rd AMNET Face-To-Face Meeting is scheduled to take place on the 05th of June 2020 in Kampala, Uganda. The Network meeting is scheduled around The International Conference on Cryptococcus & Cryptococcosis (ICCC 2020)  set for the 01st – 05th of June. 

More details to follow in the coming year!

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under Grant Agreement Number TRIA2015-1092.

This project is part of the EDCTP2 programme supported by the European Union.